USPTO serial 98533272
PARADIGMHEALTH
Reviewed by CopyMark Law Group
Status 730Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- FATHY, DOMINIC
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Need help with PARADIGMHEALTH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,545*
Plus Government fees of $750
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Perry J. Viscounty
Perry J. Viscounty Latham & Watkins LLP650 Town Center Drive, Suite 2000Costa Mesa, CA 92626United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer programs and downloadable mobile device software for use by recruiting sites, principal investigators, clinical care teams, and/or patients for clinical trials, for use in planning, designing, implementing and/or managing clinical trials, and for use in conducting research, including patient journey analyses, cohort segmentation analysis, clinical trial design analysis, patient and population risk stratification analysis, safety and efficacy analysis, and/or health economics and outcomes research for clinical trials; application program interfaces, namely, downloadable software enabling software components to interact with each other for clinical trials | ACTIVE | — |
| 035 | Business consulting and management in the field of medical clinical trials, namely, management and compilation of databases in the field of medical clinical trials for business purposes; business consulting and management in the field of medical clinical trials, namely, providing business information management services for such clinical trials; clinical trial support services, namely, providing business consultation services for clinical trial support; business management in the field of care coordination, and care navigation services in coordination with and/or on behalf of health plans, clinical trial sponsors, pharmaceutical manufacturers, physicians, hospital systems, patient advocacy organizations, and/or other medical providers, all the foregoing in connection with medial clinical trials | ACTIVE | — |
| 042 | Providing temporary use of online, non-downloadable software for use by principal investigators, recruiting sites, clinical care teams, and/or patients for clinical trials, for use in planning, designing, implementing and/or managing clinical trials and for use in conducting research, namely, patient journey analyses, cohort segmentation analysis, clinical trial design analysis, patient and population risk stratification analysis in connection with medical clinical trials, safety and efficacy analysis in connection with medical clinical trials, health economics and outcomes research, and/or comparative effectiveness analyses in connection with medical clinical trials; application service provider featuring application programming interface software for enabling software components to interact with each other in connection with medical clinical trials; providing use of online, non-downloadable software to health care providers for patient evaluation, care navigation, quality improvement, and clinical research in connection with medical clinical trials; providing use of online, non-downloadable software to health care providers, patients, advocacy organizations, and/or other parties involved in patient care to support the design, start up, conduct, and/or analysis of medical clinical trials; software as a service (SaaS) solutions featuring software for operating and managing clinical trials by third parties; software as a service (SaaS) services featuring software for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; computer software platform as a service (PaaS) featuring computer software platforms for operating and managing medical clinical trials by third parties; computer software platform as a service (PaaS) featuring computer software platforms for providing medical and scientific research information in the field of pharmaceuticals and clinical trials; clinical trial investigator services, namely, scientific research in the nature of conducting clinical trials for others; providing scientific research for medical purposes in connection with medical clinical trials; clinical trial support services, namely, scientific research in the nature of coordinating medical clinical trial research for others; virtual consulting services in connection with medical and scientific research related to clinical trials | ACTIVE | — |
| 044 | Healthcare services on behalf of health plans, clinical trial sponsors, pharmaceutical manufacturers, physicians, hospital systems, patient advocacy organizations, and other medical personnel by providing healthcare services in connection with medical clinical trials | ACTIVE | — |
| 045 | Providing clinical trial patient care case management services, namely, coordinating medical, social, and personal care services and coordinating logistical support to individuals preparing to be clinical trial participants | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by PARADIGM HEALTH, INC.
- Other trademarks owned by PARADIGM HEALTH, INC.
- Other trademarks owned by Kyra Clinical Corporation
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named PARADIGMHEALTH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2026 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 6, 2026 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Oct 5, 2026 | EXT1 | SOU EXTENSION 1 FILED | — |
| Oct 5, 2026 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 13, 2026 | NOAC | CORRECTED NOA E-MAILED | — |
| Apr 13, 2026 | CHPB | POST PUBLICATION AMENDMENT - ENTERED | — |
| Apr 13, 2026 | APET | ASSIGNED TO PETITION STAFF | — |
| Apr 7, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Feb 18, 2026 | EPPA | TEAS POST PUBLICATION AMENDMENT RECEIVED | — |
| Feb 10, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 10, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 4, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 14, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 9, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 9, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 9, 2026 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Dec 10, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Dec 10, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Sep 12, 2025 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Sep 12, 2025 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Sep 12, 2025 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 11, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 11, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 11, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 21, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 21, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 23, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 23, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 4, 2025 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Feb 4, 2025 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| Nov 26, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 26, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 26, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 30, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 23, 2024 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Sep 26, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 26, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 26, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 26, 2024 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Sep 26, 2024 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| May 3, 2024 | NWAP | NEW APPLICATION ENTERED | — |